R&D
Inspection readiness is now a commercial question
Manufacturers of advanced therapies are discovering that a digital quality system does more than satisfy inspectors.
Digital
Sponsored
The hardest part of becoming an AI-first company: It’s not t...
Axtria president and CEO Jaswinder Chadha on the culture and governance decisions behind his company’s AI transformation.
R&D
A certificate of analysis should be evidence, not a sales do...
Regulators weighing peptide bulk substances can ask whether today's documentation rules fit the risks of this supply chain.
R&D
From phase 1 to phase 3: Scaling radiopharmaceutical trials
Success in radiopharmaceutical development depends on creating and maintaining an integrated, scalable system.
Patients
Patients not just at the table, but creating their own: In c...
Donna Cryer, founding partner and Chief Patient Officer of CryerHealth, LLC discusses why is patient inclusion is not the same as patient leadership.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
